Intratumoral administration of daromun in non-melanoma skin cancer: Preliminary results from a phase 2 non-randomized controlled trial

J Eur Acad Dermatol Venereol. 2025 Feb;39(2):e147-e149. doi: 10.1111/jdv.20163. Epub 2024 Jun 22.

Authors

Affiliations

¹ Department of Dermatology, University Hospital Tuebingen, Tübingen, Germany.
² Department of Dermatology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
³ Philogen/Philochem, Otelfingen, Switzerland.

PMID: 38959382
DOI: 10.1111/jdv.20163

No abstract available

Publication types

Letter

Grants and funding

Philogen